.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Fuji
Federal Trade Commission
Boehringer Ingelheim
Baxter
Accenture
Daiichi Sankyo
Julphar
Queensland Health
Cantor Fitzgerald

Generated: June 29, 2017

DrugPatentWatch Database Preview

LEVAQUIN Drug Profile

« Back to Dashboard

Which patents cover Levaquin, and what generic Levaquin alternatives are available?

Levaquin is a drug marketed by Janssen Pharms and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in LEVAQUIN is levofloxacin. There are twenty-eight drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the levofloxacin profile page.

Summary for Tradename: LEVAQUIN

Patents:1
Applicants:1
NDAs:3
Suppliers / Packagers: see list9
Bulk Api Vendors: see list48
Clinical Trials: see list9
Patent Applications: see list5,169
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LEVAQUIN at DailyMed

Pharmacology for Tradename: LEVAQUIN

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
LEVAQUIN
levofloxacin
SOLUTION;ORAL021721-001Oct 21, 2004AARXYesYes6,806,256*PED► SubscribeY► Subscribe
Janssen Pharms
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
levofloxacin
INJECTABLE;INJECTION020635-002Dec 20, 1996DISCNYesNo► Subscribe► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
TABLET;ORAL020634-003Sep 8, 2000ABRXYesYes► Subscribe► Subscribe
Janssen Pharms
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
levofloxacin
INJECTABLE;INJECTION020635-003Dec 20, 1996DISCNYesNo► Subscribe► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
TABLET;ORAL020634-001Dec 20, 1996ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LEVAQUIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
LEVAQUIN
levofloxacin
TABLET;ORAL020634-002Dec 20, 19964,382,892► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
TABLET;ORAL020634-003Sep 8, 20005,053,407*PED► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
SOLUTION;ORAL021721-001Oct 21, 20045,053,407*PED► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
TABLET;ORAL020634-001Dec 20, 19965,053,407*PED► Subscribe
Janssen Pharms
LEVAQUIN
levofloxacin
INJECTABLE;INJECTION020635-001Dec 20, 19964,382,892► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: LEVAQUIN

Drugname Dosage Strength RLD Submissiondate
levofloxacinOral Solution25 mg/mLLevaquin7/30/2009
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
McKesson
Federal Trade Commission
Colorcon
Citi
Harvard Business School
Argus Health
Fish and Richardson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot